Raia Drogasil S.A. RADLY
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 9.10% | -10.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.10% | -10.44% | |||
| Cost of Revenue | 7.00% | -13.82% | |||
| Gross Profit | 13.55% | -2.34% | |||
| SG&A Expenses | 8.33% | -0.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -96.91% | -- | |||
| Total Operating Expenses | 5.38% | -8.67% | |||
| Operating Income | 91.63% | -37.41% | |||
| Income Before Tax | 335.95% | -57.10% | |||
| Income Tax Expenses | 680.83% | -266.15% | |||
| Earnings from Continuing Operations | 194.61% | -48.01% | |||
| Earnings from Discontinued Operations | -26.17% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 178.38% | -46.53% | |||
| EBIT | 91.63% | -37.41% | |||
| EBITDA | 64.80% | -33.16% | |||
| EPS Basic | 178.69% | -49.86% | |||
| Normalized Basic EPS | 313.98% | -67.37% | |||
| EPS Diluted | 182.02% | -51.10% | |||
| Normalized Diluted EPS | 316.48% | -67.96% | |||
| Average Basic Shares Outstanding | 0.01% | 6.40% | |||
| Average Diluted Shares Outstanding | -1.02% | 9.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 186.88% | -1.00% | |||